| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459403 | Radiotherapy and Oncology | 2017 | 6 Pages |
Abstract
Several PET metrics were associated with risk of recurrence. Progression on mid-radiotherapy PET/CT was a poor prognostic factor.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Michael F. Gensheimer, Julian C. Hong, Christine Chang-Halpenny, Hui Zhu, Neville C.W. Eclov, Jacqueline To, James D. Murphy, Heather A. Wakelee, Joel W. Neal, Quynh-Thu Le, Wendy Y. Hara, Andrew Quon, Peter G. Maxim, Edward E. Graves, Michael R. Olson,